| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amgen Inc (AMGN) has 22 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. AMGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 507.2K | $167.82M | - | |
| VP | 83.4K | $27.58M | - | |
| VP | 51.8K | $17.15M | - | |
| CFO | 50.7K | $16.78M | - | |
| VP | 42.8K | $14.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | Graham Jonathan P | EVP &Gen. Counsel &Secy. | Sale+OE | 25,045 | $293.12 | $7,341,122.78 | -46.4% | -7.3% | +30.9% | |
| Feb 5, 2025 | Grygiel Nancy A.55 | SVP &CCO | Sell | 1,589 | $304.47 | $483,807.76 | -18.1% | -12.1% | +19.5% | |
| May 3, 2024 | Grygiel Nancy A.55 | SVP &CCO | Sell | 2,117 | $313.09 | $662,801.58 | -17.6% | +7.8% | -9.7% | |
| Dec 4, 2023 | Grygiel Nancy A.55 | SVP &CCO | Sell | 2,096 | $273.03 | $572,275.70 | -16.2% | +2.5% | +2.1% | |
| Nov 8, 2023 | Graham Jonathan P | EVP, Gen. Counsel &Secy. | Sell | 10,000 | $272.81 | $2,728,136.00 | -26.3% | +15.7% | +17.8% | |
| Sep 19, 2023 | Amgen Inc | 10% Owner | Buy | 1,764,705 | $17.00 | $29,999,985.00 | +5.3% | +4.2% | +26.0% | |
| Aug 10, 2023 | Gordon Murdo | EVP, Global Commercial Ops | Sell | 9,558 | $262.43 | $2,508,305.94 | -17.7% | +4.3% | +23.1% | |
| Nov 9, 2022 | Khosla Rachna60 | SVP, Business Development | Sell | 387 | $292.90 | $113,352.30 | -5.5% | -15.2% | -8.2% | |
| Nov 8, 2022 | Grygiel Nancy A.55 | SVP &CCO | Sell | 545 | $293.54 | $159,976.58 | -4.0% | -16.0% | -5.9% | |
| Aug 22, 2022 | Williams R Sanders54 | Director | Sell | 200 | $249.96 | $49,992.00 | -3.6% | +17.5% | +5.1% |